Quick answers
- What is Captopril and hydrochlorothiazide used for?
- The FDA-approved label (Captopril and Hydrochlorothiazide, Rising Pharma Holdings, Inc., February 21, 2023) says: “Captopril and hydrochlorothiazide tablets are indicated for the treatment of hypertension. The blood pressure lowering effects of captopril and thiazides are approximately additive. This fixed combination drug may be used as initial therapy or substituted for previously titrated doses of the individual components. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Captopril and hydrochlorothiazide have a boxed warning?
- Yes. The FDA label for Captopril and Hydrochlorothiazide has a boxed warning, the FDA’s strongest warning. Read it on the full label and ask your pharmacist.
- Is there a shortage of Captopril and hydrochlorothiazide?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Captopril and hydrochlorothiazide been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Captopril and hydrochlorothiazide?
- 1 company lists prescription products of Captopril and hydrochlorothiazide in the FDA NDC Directory, including Rising Pharma Holdings, Inc..
What Captopril and hydrochlorothiazide is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Captopril and hydrochlorothiazide tablets are indicated for the treatment of hypertension. The blood pressure lowering effects of captopril and thiazides are approximately additive. This fixed combination drug may be used as initial therapy or substituted for previously titrated doses of the individual components. …
— FDA label: Captopril and Hydrochlorothiazide, Rising Pharma Holdings, Inc., effective February 21, 2023. Read the full label on DailyMed →
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Conditions named on the label
These condition names appear word for word in the label’s “Indications and Usage” text (matched with a reviewed table). Each page lists hospitals whose own websites name the condition.
Related medical specialties
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
This label has a boxed warning. Read it on the full label →
Forms and how it is given
| Dosage forms | Tablet |
|---|---|
| Route | Oral |
| Prescription products | 4 in the FDA NDC Directory |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Rising Pharma Holdings, Inc.4 products
FDA approval history
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
Generic approvals (1)
- ANDA074896Rising · December 29, 1997
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| RxCUI (RxNorm) | 197436, 197437, 197438, 197439 |
|---|---|
| SPL set ID of the quoted label | 0ea90fd4-0da6-4ad2-ab83-6cfbe0ae515e |
| FDA labels (SPL) | 1 |
| FDA applications | 1 ANDA |
| Active ingredients (FDA) | CAPTOPRIL / HYDROCHLOROTHIAZIDE |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Captopril and Hydrochlorothiazide, Rising Pharma Holdings, Inc., effective February 21, 2023; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →